ERBB2 and breast carcinoma: The observed reduction in STAT1 expression suggests a feedback regulatory mechanism of pSTAT1 on its own promoter, already documented,35 as well as an EGFR/HER2-dependent regulation as previously shown in glioblastoma and breast cancer cell lines.48